Clinical Trial

Potassium-Competitive Acid Blocker Versus Proton Pump Inhibitor as A Part of Bismuth Based Quadruple Therapy for Treatment of Helicobacter Pylori Infection

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 12, 2025 (before its estimated February 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to compare the eradication rate, safety, and patient adherence between potassium-competitive acid blockers (P-CABs) and proton pump inhibitor-based bismuth quadruple therapy in patients with Helicobacter pylori infection.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-03.
Status change: Not Yet Recruiting → Recruiting 2025-09-11
Trial Details
NCT Number NCT07165444
Lead Sponsor Tanta University
Conditions Potassium-Competitive Acid Blocker, Proton Pump Inhibitor, Bismuth Based Quadruple Therapy, Treatment, Helicobacter Pylori Infection
Enrollment 320 participants
Start Date 2025-09-11
Primary Completion 2026-02-01 (estimated)
Study Completion 2026-02-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-12